- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01746329
Tea-beetroot-venous Occlusion Plethysmography
August 2, 2013 updated by: Unilever R&D
Exploratory Study on the Effect of Nutritional Intervention on Postprandial Skeletal Muscle Microcirculation in Obese Subjects
In the present study, muscle perfusion will be studied before and after an oral glucose challenge following a fasting period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Based on data from previous studies, this physiological response is blunted in obese subjects, and the investigators expect these responses to be restored when the glucose load is combined with tea or beetroot juice in obese, insulin resistant men.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6500 HB
- Radboud University Nijmegen Medical Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male sex
- Aged 30-70 years.
- Obesity (BMI>30 kg/m2)
- insulin resistance as fasting glucose levels >6.1 mmol/L.
- Reported intense sport activities >10 h/w.
- Reported alcohol consumption >28 units/w
- Signed Informed consent
- Currently not smoking and being a non-smoker for at least 3 months prior to the start of the study.
Exclusion Criteria:
- BMI ≥ 40 kg/m2.
- Presence of cardiovascular disease.
- Presence of sudden cardiac death in a 1st degree relative at an age <50 years.
- Presence of diabetes mellitus type 2.
- Regular tea drinker (> 2 cups per day)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Tea
Oral intake of tea containing 75 grams of glucose
|
Oral intake of tea containing 75 grams of glucose
|
|
EXPERIMENTAL: Beet root
Oral intake of beetroot juice containing 75 grams of glucose
|
Oral intake of beetroot juice containing 75 grams of glucose
|
|
PLACEBO_COMPARATOR: Placebo
Oral intake of 75 grams of glucose in water
|
Oral intake of 75 grams of glucose in water
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vascular resistance
Time Frame: Average of values obtained at 30, 60, 90, 120, 150 and 180 minutes after test product intake corrected for the value obtained at approximately 20 minutes before test product intake (baseline)
|
Vascular resistance (arm and leg) as obtained from venous occlusion plethysmography and corrected for blood pressure
|
Average of values obtained at 30, 60, 90, 120, 150 and 180 minutes after test product intake corrected for the value obtained at approximately 20 minutes before test product intake (baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
echo-Doppler
Time Frame: Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake
|
Postprandial muscle blood flow (arm and leg) measured by echo-Doppler at the brachial artery and the superficial femoral artery
|
Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake
|
|
Near-infrared spectroscopy
Time Frame: Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake
|
Postprandial muscle blood flow (arm) measured by near-infrared spectroscopy on the extensor carpi radialis brevis muscles of the forearm
|
Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake
|
|
Glucose and insulin
Time Frame: Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake
|
Glucose and insulin in venous blood plasma
|
Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake
|
|
Vascular resistance exploratory
Time Frame: Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake
|
Vascular resistance (arm and leg) as obtained from venous occlusion plethysmography and corrected for blood pressure as an exploratory parameter.
|
Approximately 20 minutes before (baseline) and 30, 60, 90, 120, 150 and 180 minutes after test product intake
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: M Hopman, Prof DR, Radboud University Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (ACTUAL)
April 1, 2013
Study Completion (ACTUAL)
May 1, 2013
Study Registration Dates
First Submitted
November 30, 2012
First Submitted That Met QC Criteria
December 7, 2012
First Posted (ESTIMATE)
December 10, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
August 5, 2013
Last Update Submitted That Met QC Criteria
August 2, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FDS-BNH-0809
- Arnhem-Nijmegen 2012/357 (OTHER: Commissie Mensgebonden Onderzoek)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Tea
-
Sir Run Run Shaw HospitalNot yet recruitingColorectal Cancer (CRC)China
-
Providence Health & ServicesCompletedMetastatic Sarcoma | Metastatic Carcinoma | Metastatic LymphomaUnited States
-
National University of SingaporeTea Explorer Pte. Ltd.Active, not recruiting
-
IsuraCompletedSafety | Bioavailability and PharmacokineticsCanada
-
University of ArizonaUnited States Department of DefenseCompletedLung Cancer Prevention
-
University of LahoreCompleted
-
Northumbria UniversityFinzelbergCompletedCognitive Change | Blood Pressure | Affect | NeuroimagingUnited Kingdom
-
University of Missouri-ColumbiaCompletedGlucose | Blood Sugar; High | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Conselho Nacional de Desenvolvimento... and other collaboratorsCompleted
-
Universitas PadjadjaranCompleted